Tuberculin sensitivity testing and treatment of latent tuberculosis remains effective for tuberculosis control in human immunodeficiency virus-infected patients in Hong Kong

Hong Kong Medical Journal

Volumn 19, Issue 5, 2013, Pages 386-392

  Lin, Ada W C ^a   Chan, Kenny C W ^a   Chan, W K ^a   Wong, K H ^a  

^a DEPARTMENT OF HEALTH   (Hong Kong)

Author keywords

Antiretroviral therapy; Highly active; HIV; Latent tuberculosis; Tuberculin test; Tuberculosis

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; FEMALE; HEALTH CARE POLICY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HONG KONG; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; LATENT TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; RISK ASSESSMENT; RISK FACTOR; TREATMENT DURATION; TUBERCULIN TEST; TUBERCULOSIS CONTROL;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; HIV; LATENT TUBERCULOSIS; TUBERCULIN TEST; TUBERCULOSIS;

ADULT; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; FEMALE; HEALTH POLICY; HIV INFECTIONS; HONG KONG; HUMANS; INCIDENCE; LATENT TUBERCULOSIS; MALE; MASS SCREENING; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; TUBERCULIN TEST; TUBERCULOSIS; YOUNG ADULT;

EID: 84885163955     PISSN: 10242708     EISSN: None     Source Type: Journal    
DOI: 10.12809/hkmj133892     Document Type: Article

References (25)

1. Lawn SD, Churchyard G. Epidemiology of HIV-associated tuberculosis. Curr Opin HIV AIDS 2009;4:325-33.
2. World Health Organization. Global tuberculosis control. A short update to the 2009 report. Geneva: WHO; 2009.
3. Grant AD, Charalambous S, Fielding KL, et al. Effect of routine isoniazid preventive therapy on tuberculosis incidence among HIV-infected men in South Africa. JAMA 2005;293:2719-25.
4. Badri M, Wilson D, Wood R. Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study. Lancet 2002;359:2059-64.
5. Girardi E, Antonucci G, Vanavore P, et al. Impact of combination antiretroviral therapy on the risk of tuberculosis among persons with HIV infection. AIDS 2000;14:1985-91.
6. Virtual AIDS office, Centre for Health Protection, Department of Health, Hong Kong. HIV surveillance report-2010 update. Available from: http://www.info.gov.hk/ aids/english/surveillance/sur_archives.htm. Accessed 17 Jul 2013.
7. Centre for Health Protection, Department of Health, Hong Kong. Annual report 2009. Tuberculosis and chest service. Available from: http://www.info.gov.hk/tb_chest/doc/ AnnualReport2009.pdf. Accessed 6 Jun 2012.
8. Virtual AIDS office, Centre for Health Protection, Department of Health, Hong Kong. Available from: http://www.info.gov. hk/aids/english/index.htm. Accessed 6 Jun 2012.
9. Scientific Committee on AIDS, Centre for Health Protection, Department of Health, Hong Kong. Recommended principles of antiretroviral therapy in HIV disease. Available from: http://www.info.gov.hk/aids/english/publications/ pubsearch_2.htm. Accessed 17 Jul 2013.
10. Chan CK, Alvarez Bognar F, Wong KH, et al. The epidemiology and clinical manifestations of human immunodeficiency virus-associated tuberculosis in Hong Kong. Hong Kong Med J 2010;16:192-8.
11. Golub JE, Saraceni V, Cavalcante SC, et al. The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil. AIDS 2007;21:1441-8.
12. Zhou J, Elliott J, Li PC, et al. Risk and prognostic significance of tuberculosis in patients from The TREAT Asia HIV Observational Database. BMC Infect Dis 2009;9:46.
13. Antiretroviral Therapy in Low-Income Countries Collaboration of the International epidemiological Databases to Evaluate AIDS (IeDEA); ART Cohort Collaboration, Brinkhof MW, Egger M, Boulle A, et al. Tuberculosis after initiation of antiretroviral therapy in low-income and highincome countries. Clin Infect Dis 2007;45:1518-21.
14. Rajasekaran S, Raja K, Jeyaseelan L, et al. Post-HAART tuberculosis in adults and adolescents with HIV in India: incidence, clinical and immunological profile. Indian J Tuberc 2009;56:69-76.
15. Taarnhøj GA, Engsig FN, Ravn P, et al. Incidence, risk factors and mortality of tuberculosis in Danish HIV patients 1995-2007. BMC Pulm Med 2011;11:26.
16. Van Rie A, Westreich D, Sanne I. Tuberculosis in patients receiving antiretroviral treatment: incidence, risk factors, and prevention strategies. J Acquir Immune Defic Syndr 2011;56:349-55.
17. Lawn SD, Myer L, Edwards D, Bekker LG, Wood R. Shortterm and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa. AIDS 2009;23:1717-25.
18. Lawn SD, Badri M, Wood R. Tuberculosis among HIVinfected patients receiving HAART: long term incidence and risk factors in a South African cohort. AIDS 2005;19:2109-16.
19. Churchyard GJ, Fielding KL, Lewis JJ, et al. Community-wide isoniazid preventive therapy does not improve tuberculosis control among gold miners; the Thibela TB study, South Africa. Proceedings of the 19th Conference on Retroviruses and Opportunistic Infections; 2012 Mar 5-8; Seattle, United States.
20. Mardani M, Tabarsi P, Mohammadtaheri Z, et al. Performance of QuantiFEROM-TB Gold test compared to tuberculin skin test in detecting latent tuberculosis infection in HIV-positive individuals in Iran. Ann Thorac Med 2010;5:43-6.
21. Talati NJ, Seybold U, Humphrey B, et al. Poor concordance between interferon-gamma release assays and tuberculin skin tests in diagnosis of latent tuberculosis infection among HIV-infected individuals. BMC Infect Dis 2009;9:15.
22. Oni T, Gideon HP, Bangani N, et al. Risk factors associated with indeterminate gamma interferon responses in the assessment of latent tuberculosis infection in a high-incidence environment. Clin Vaccine Immunol 2012;19:1243-7.
23. Shanaube K, Hargreaves J, Fielding K, et al. Risk factors associated with positive QuantiFERON-TB Gold In-tube and tuberculin skin tests results in Zambia and South Africa. PLoS One 2011;6:e18206.
24. Cattamanchi A, Smith R, Steingart KR, et al. Interferongamma release assays for the diagnosis of latent tuberculosis infection in HIV-infected individuals: a systematic review and meta-analysis. J Acquir Immune Defic Syndr 2011;56:230-8.
25. Jones JL, Hanson DL, Dworkin MS, et al. HIV-associated tuberculosis in the era of highly active antiretroviral therapy. The Adult/Adolescent Spectrum of HIV Disease Group. Int J Tuberc Lung Dis 2000;4:1026-31.